PathGen raises funding from East Ventures and Royal Group Indonesia, making early disease detection and precision medicine more accessible
PathGen or PathGen Diagnostik Teknologi, an Indonesia-based healthcare biotechnology startup specializing in molecular testing solutions, has raised funding from East Ventures and Royal Group Indonesia